Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches

Overview of attention for article published in Radiation Oncology, January 2011

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 78 Dimensions

Readers on

mendeley: 114 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MONOCLONAL ANTIBODIES TO ELTD1 AND USES THEREOF

Application EP-4219550-A1

European Patent Office

Biomarkers for predicting the response to anti-angiogenic cancer therapy

Application EP-3006940-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.